Search for: "ACCESS THERAPIES, INC" Results 41 - 60 of 270
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2017, 1:55 pm by Tom Lamb
Immediately and permanently discontinue Aranesp and administer appropriate therapy if a serious allergic or anaphylactic reaction occurs. [read post]
27 Sep 2016, 1:55 pm by Tom Lamb
Savaysa has the following so-called  "indications" or approved uses:  To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation; and,  For the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) following 5–10 days of initial therapy with parenteral anticoagulant. [read post]
8 Apr 2019, 7:29 am by Kathy Tiemeier
Gilead Sciences, Inc., the manufacturer of both medications, made them accessible through a newly created subsidiary, Asegua Therapeutics LLC. [read post]
8 Mar 2012, 4:00 am
The fundraiser was set to support the national advocacy group, Cerebral Palsy, Inc. [read post]
1 Feb 2008, 1:07 am
Ellen Tauscher and Phil EnglishLetter Titled, "The Ensuring Medicare Access to Recreational Therapy Act of 2007"01/31/2008 Dear Colleague From Reps. [read post]
5 May 2013, 7:33 pm by David Jensen
Klein said McEwen does not engage in technical discussions and added, “On a conceptual basis it was important for him to understand the spectrum of medical advances towards therapies. [read post]
28 Feb 2011, 4:00 pm by FDABlog HPM
Clissold – In a federal lawsuit filed on Friday, February 25, 2011 in the District of Columbia, Lorillard, Inc., Lorillard Tobacco Company, and R.J. [read post]
27 Feb 2018, 9:12 am by Tom Lamb
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
1 Mar 2010, 8:56 am by Green and Associates
The six purported clinics involved in the fraud were: Zigma Medical Care, Inc., Tender Loving Care Medical Center, Inc, Professional Medical Health, Inc., Metro Med Care, Inc., San Diego Medical & Rehab Center, Inc., and Eulogia's Diagnostic Medical Center, Inc. [read post]
10 Oct 2008, 3:22 pm
A senior consulting cardiologist then accessed the FDA’s Manufacturer and User Facility Device Experience database (MAUDE), which contains adverse event reports involving medical devices. [read post]
25 Jul 2008, 9:40 pm
International Village contracted for its residents to receive dialysis services provided by Affiliated Dialysis Center, Inc and Renal Therapies, LLC. [read post]
14 Oct 2009, 6:00 am
OxyHeal Medical Systems Inc. of National City, Calif., will develop new products based on technologies NASA originally developed for space. [read post]